Clinical Trial Update: Study of the Effect of Dosing on Clozapine Levels [Phase 4]

View source ↗

Summary

Phase 4 trial investigating how dosing impacts clozapine levels was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: University of British Columbia | Conditions: Psychotic Disorders, Schizophrenia | Phase 4 | Status: WITHDRAWN